Clive R. Seed

3.6k citations

96 papers · 2.0k indexed · h-index 25

Epidemiology top 2%
Hepatology top 1%
Infectious Diseases top 2%
Management of Technology and Innovation top 0.5%
Public Health, Environmental and Occupational Health top 5%

Co-authors: A. J. Keller Philip Kiely T.J. Cobain E. A. C. Follett Tom Krusius P.L. Yap F. McOmish Elina Kolho
Topics: Blood donation and transfusion practices (28 papers)Hepatitis B Virus Studies (26 papers)Hepatitis C virus research (26 papers)
Cited by: Hepatology Management of Technology and Innovation Infectious Diseases
Journals: Journal of Clinical Microbiology Emerging infectious diseases American Journal of Transplantation
Partner nations: Australia United States United Kingdom

In The Last Decade

Clive R. Seed

90 papers receiving 2.0k citations

Peers

Countries citing papers authored by Clive R. Seed

Since Specialization

Citations

This map shows the geographic impact of Clive R. Seed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clive R. Seed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clive R. Seed more than expected).

Fields of papers citing papers by Clive R. Seed

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clive R. Seed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clive R. Seed. The network helps show where Clive R. Seed may publish in the future.

Co-authorship network of co-authors of Clive R. Seed

This figure shows the co-authorship network connecting the top 25 collaborators of Clive R. Seed. A scholar is included among the top collaborators of Clive R. Seed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clive R. Seed. Clive R. Seed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Removal of UK‐donor deferral for variant Creutzfeldt–Jakob disease: A large donation gain in Australia 2023 ·Vox Sanguinis ·Veronica C. Hoad,Clive R. Seed,Philip Kiely,(unknown),Hamish McManus,Matthew Law,John Kaldor,Iain B. Gosbell	2
2	Is dual testing for hepatitis C necessary? Modelling the risk of removing hepatitis C antibody testing for Australian blood donations 2023 ·Vox Sanguinis ·(unknown),Veronica C. Hoad,Clive R. Seed,P.J. Bentley	2
3	Removing hepatitis C antibody testing for Australian blood donations: A cost‐effectiveness analysis 2023 ·Vox Sanguinis ·Qinglu Cheng,Veronica C. Hoad,(unknown),Clive R. Seed,P.J. Bentley,Sophy Shih,Jisoo A. Kwon,Richard T. Gray,Virginia Wiseman	3
4	Severe Acute Respiratory Syndrome Coronavirus 2 and Blood Safety: An Updated Review 2022 ·Transfusion Medicine and Hemotherapy ·Philip Kiely,Veronica C. Hoad,Clive R. Seed,Iain B. Gosbell	3
5	HIV residual risk in Canada for apheresis source plasma donation without deferral for men who have sex with men 2021 ·Vox Sanguinis ·(unknown),Antoine Lewin,Sheila F. O’Brien,Yves Grégoire,Josiane Pillonel,Whitney R. Steele,Brian Custer,Katy Davison,Marc Germain,Clive R. Seed,(unknown),(unknown)	6
6	Current challenges of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence studies among blood donors: A scoping review 2021 ·medRxiv ·Sahar Saeed,(unknown),Antoine Lewin,(unknown),Helen M. Faddy,Christian Erikstrup,Carla Osiowy,Clive R. Seed,Whitney R. Steele,(unknown),Brian Custer,Sheila F. O’Brien	4
7	Current challenges of severe acute respiratory syndrome coronavirus 2 seroprevalence studies among blood donors: A scoping review 2021 ·Vox Sanguinis ·Sahar Saeed,(unknown),Antoine Lewin,(unknown),Helen M. Faddy,Christian Erikstrup,Carla Osiowy,Clive R. Seed,Whitney R. Steele,Katy Davison,Brian Custer,Sheila F. O’Brien,(unknown)	6
8	Effect of HIV pre‐exposure prophylaxis (PrEP) on detection of early infection and its impact on the appropriate post‐PrEP deferral period 2020 ·Vox Sanguinis ·Clive R. Seed,(unknown),Veronica C. Hoad,Hung‐Chih Yang,Michael J. Thomas,Iain B. Gosbell	18
9	Excluding Occult Hepatitis B Infection before Assigning False-Positive Status to Non-Repeatable NAT Reactivity: Concerning Stolz et al. “Safe-Testing Algorithm for Individual-Donation Nucleic Acid Testing: 10 Years of Experience in a Low-Prevalence Country” [Transfus Med Hemother. 2019 Apr;46(2):104–10] 2019 ·Transfusion Medicine and Hemotherapy ·(unknown),(unknown),Veronica C. Hoad,Philip Kiely,Michael Watson,Clive R. Seed	3
10	Undetectable does not equal untransmittable for HIV and blood transfusion 2019 ·Vox Sanguinis ·Iain B. Gosbell,Veronica C. Hoad,(unknown),June Lee,Clive R. Seed	13
11	Changing the deferral for men who have sex with men – an improved model to estimate HIV residual risk 2019 ·Vox Sanguinis ·Katy Davison,Yves Grégoire,Marc Germain,Brian Custer,Sheila F. O’Brien,Whitney R. Steele,Josiane Pillonel,Clive R. Seed,(unknown)	15
12	HIV residual risk in Canada under a three‐month deferral for men who have sex with men 2019 ·Vox Sanguinis ·Sheila F. O’Brien,Yves Grégoire,Josiane Pillonel,Whitney R. Steele,Brian Custer,Katy Davison,Marc Germain,Antoine Lewin,Clive R. Seed,(unknown)	23
13	Confirming transfusion‐transmitted viral infections in the molecular age: time to get back to the basic definition of infection for hemovigilance 2019 ·Transfusion ·Veronica C. Hoad,(unknown),Clive R. Seed,Philip Kiely,Iain B. Gosbell	0
14	Blood safety assessment of hepatitis A outbreak linked to frozen pomegranate arils: are foodborne outbreaks an emerging blood safety risk? 2019 ·Transfusion ·(unknown),Veronica C. Hoad,Philip Kiely,Clive R. Seed,Iain B. Gosbell	0
15	Modelling the risk of transfusion‐transmitted syphilis: a reconsideration of blood donation testing strategies 2018 ·Vox Sanguinis ·(unknown),Veronica C. Hoad,(unknown),Clive R. Seed,P.J. Bentley,Vanessa Clifford,(unknown),(unknown)	14
16	Estimation of human T‐lymphotropic virus incidence in blood donors from observed prevalence 2018 ·Vox Sanguinis ·(unknown),Veronica C. Hoad,Clive R. Seed	6
17	Hepatitis E virus infections in travellers: assessing the threat to the Australian blood supply. 2017 ·PubMed ·Ashish C. Shrestha,Robert L. Flower,Clive R. Seed,A. J. Keller,Veronica C. Hoad,(unknown),(unknown),Ben Polkinghorne,(unknown),Helen M. Faddy	4
18	Reconsideration of blood donation testing strategy for human T‐cell lymphotropic virus in Australia 2017 ·Vox Sanguinis ·(unknown),Clive R. Seed,Veronica C. Hoad,Silvana Gaudieri,A. J. Keller	18
19	The Epidemiology of Imported Malaria and Transfusion Policy in 5 Nonendemic Countries 2015 ·Transfusion Medicine Reviews ·Sheila F. O’Brien,Gilles Delage,Clive R. Seed,Josiane Pillonel,(unknown),Katy Davison,Alan D. Kitchen,Whitney R. Steele,David A. Leiby	44
20	Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus 2005 ·Internal Medicine Journal ·Clive R. Seed,Philip Kiely,A. J. Keller	72

About Clive R. Seed

Clive R. Seed is a scholar working on Hepatology, Management of Technology and Innovation and Infectious Diseases, having authored 96 papers that have together received 2.0k indexed citations. Recurring topics across this work include Blood donation and transfusion practices (28 papers), Hepatitis B Virus Studies (26 papers) and Hepatitis C virus research (26 papers). The work is most often cited by research in Hepatology (950 citations), Management of Technology and Innovation (516 citations) and Infectious Diseases (627 citations). Clive R. Seed has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include A. J. Keller, Philip Kiely, T.J. Cobain, E. A. C. Follett, Tom Krusius, P.L. Yap, F. McOmish, Elina Kolho, B. C. Dow and R. Naukkarinen. Their work appears in journals such as Journal of Clinical Microbiology, Emerging infectious diseases and American Journal of Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact